Clinical evidence-based cutoff limits for GH stimulation tests in children with a backup of results with reference to mass spectrometry

Abstract

The establishment of method-specific clinical evidence-based GH cutoff limits is of importance to ensure adequate clinical diagnosis and treatment of children and adolescents with GHD. ID-MS may become an important tool for providing both reliable and sustainable SI traceability of GH measurements in the future.